During development, nervous tissue is differentiated at a very early stage from ectoderm to form the neural tube. This event is followed by the formation of the neural crest, which in turn gives rise to the peripheral nervous system through migration of cells. At the neural crest stage, nerve stem cells have potential to become both neuronal and glial cell types (1) (2) (3) . Multipotential neural crest cells migrate to their correct destination and generate glial and neuronal cell types. There is a strong possibility that these migrating cells are still at the stem cell stage and retain the potential to generate neuroblasts and glioblasts as well as to renew stem cells (2) (3) (4) (5) . Thus, there must be at least two major regulatory mechanisms for neural system development: one for the determination of neural tissue lineage (tissue-specific regulation) and another for the determination of neurons and glial cells from common neural stem cells (cell type-specific regulation).
Previous work established clonal cell lines from an ethylnitrosourea-induced rat peripheral neurotumor, RT4 (6, 7) . The RT4 cell-line family has a stem cell type, RT4-AC, where daughter cells have been repeatedly shown to spontaneously and irreversibly differentiate into one of three derivative cell types at a frequency of 10-5: a glial type, RT4-D, and two neuronal types, RT4-E and RT4-B. The glial type, RT4-D, expresses only glial-specific gene products, including glial fibrillary acidic protein (GFAP), S100(3, P0, suppressed cAMP-inducible POU protein, a low level of myelin basic protein, and 2',3'-cyclic 3'-nucleotide phosphodiesterase (refs. 8-10 ; N. Hagiwara, S. Imada, and N.S., unpublished work). The two neuronal types, RT4-B and RT4-E, exhibit only neuronal characteristics, including the expression of voltage-dependent Na+ and K+ channels and extension of neurite-like processes (7, 11, 12) . The parental stem-cell type, RT4-AC, expresses both glial and neuronal phenotypes (7, 12) . Therefore, differential suppression of neuronal and glial genes occurs upon conversion ofthe stem cell type to the glial or neuronal cell type. These properties of the RT4 cell lines reflect the in vivo situation in both the central (13) (14) (15) (16) and the peripheral (4, 5) nervous system. RT4-AC and its derivative cell types grow indefinitely in culture, so they provide an excellent system for the molecular study of regulatory mechanisms of neuronal-and glial-specific gene expression (17) , in particular (a) suppression of both glial and neuronal gene expressions in non-neural cells (tissue-specific regulation) and (b) suppression of glial genes in the neuronal cell types, RT4-B and RT4-E, and suppression of neuronal genes in the glial cell type, RT4-D (cell type-specific regulation).
GFAP is an intermediate-filament protein expressed primarily in astrocytes and Schwann cells (18) and is well characterized histocytochemically (19, 20) . Modulation of GFAP gene expression during development, wound healing, and disease has been observed (21) (22) (23) . In this report, we describe the existence of two regulatory regions of the GFAP gene that are located downstream of the transcription start site; one is responsible for the tissue-specific regulation (nervous tissue versus other tissues), and both regions are necessary for the regulation of cell type-specific expression (neuronal cells versus glial cells).
MATERIALS AND METHODS
Cell Lines and Culture Conditions. RT4 clonal lines used in these studies were RT4-AC36A, RT4-B8, RT4-D6, and RT4-E5 (6) . Rat hepatocytoma cell line HTC was originally obtained from the late G. M. Tomkins. Rat mammary carcinoma cell line 64-24 was obtained from T. Kano-Sueoka (24) . Rat pheochromocytoma cell line PC12, rat astrocytoma cell line C6, and rat kidney fibroblast cell line NRK-49F were purchased from the American Type Culture Collection. RT4 cells and NRK-49F cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf serum. C6 cells were cultured in DMEM supplemented with 15% horse serum and 2.5% fetal bovine serum. HTC cells and 64-24 cells were cultured in DMEM supplemented with 8% horse serum and 8% fetal bovine serum.
Permanent and Transient Transfection. Permanent transfection of RT4-E was carried out with pUC19 or AEMBL3 vectors carrying various portions of the GFAP gene, and expression of fibrous GFAP was examined by fluorescent immunostaining. RT4-E cells were transfected with 75 ,ug of pX14 plasmid or 100 pg of A GFAP vectors plus 1 ug of pRSVneo plasmid (Fig. 1) by the calcium phosphate method (28) . DNAs used for transfection were purified by two rounds of CsCl/ethidium bromide equilibrium ultracentrifugation. Two days after transfection, G418 (400 ,ug/ml) was added, cells were incubated for 2 weeks, G418-resistant colonies were selected, and individual colonies were isolated. Immunostaining was performed with mouse anti-human GFAP Abbreviations: GFAP, glial fibrillary acidic protein; GDR, GFAP downstream regulator. *Present address: Nippon Petrochemicals Company, 1-3-1 Uchisaiwaicho, Chiyoda-ku, Tokyo 100, Japan.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (25, 30) . Although the nucleotide sequence of the entire rat GFAP gene is not available at present, there is the following supportive evidence indicating that the structure ofthe rat GFAP gene is similar to that of the mouse GFAP gene: (i) the sequence of 2 kb of the upstream region closest to the transcription start site of the rat GFAP gene (R.K., N. Hagiwara, and N.S., unpublished) shows 94% identity to the corresponding region of the mouse GFAP gene (25, 30) ; (ii) we have also sequenced a 200 bp of a rat clone positioned 6 kb downstream of the transcription start site, which showed 98% identity to the mouse sequence at a comparable position (the end of the sixth exon) of the mouse gene (25) ; and (iii) expression vector pX14 (see below Fig. 2) , which contains the entire coding region (including the polyadenylylation site predicted from the mouse sequence), allowed expression of GFAP in transfected cells (this work), indicating that the rat polyadenylylation site is most likely in a similar region to that of the mouse. For analysis of the regions of the rat GFAP gene downstream of the transcription start site, we therefore assume that the lengths and arrangements of the exons and introns and the positions of the polyadenylylation site are similar in mouse and rat (Figs. 1 and 2) .
To define whether specific regions of the gene were necessary for glial-specific expression of GFAP, expression vectors were constructed using the luciferase expression vector pXP1 for transient transfections (26, 27) and using pUC19 and AEMBL3 for permanent transfections. We initially sought to define whether any regulatory sequences were located in the 2-kb region immediately 5' to the transcription start site. The luciferase expression vector pGL2 (Fig. 1A) (Fig. 1A) . The 5' flanking region (up to 10.8 kb) of the rat GFAP gene is apparently not sufficient to suppress GFAP expression in any rat cell types tested. These results suggest that tissueand cell type-specific regulatory elements lie elsewhere, either further upstream or downstream of the transcription start site.
To determine whether regions downstream of the transcription start site were involved in glial-specific regulation of GFAP, segments of the gene were cloned into expression vectors and permanent transfectants were established by using the neuronal cell line RT4-E as the recipient. Two GFAP expression vectors were used: a genomic clone, pX14 (which contains DNA sequences from -4 kb to +10 kb relative to the transcription start site, including the entire coding region through the polyadenylylation site), and a A GFAP clone (which contains DNA sequences from -7 kb to +13 kb relative to the transcription start site, including the entire coding region through the polyadenylylation site, and 3 kb downstream of the polyadenylylation site) (Fig. 2) . GFAP expression was assayed by immunological staining. Interestingly, with the pX14 transfectants, 150 out of 150 individual clones showed a GFAP fiber network stained with anti-GFAP antibody, whereas in the A GFAP transfectants, To analyze the downstream region further, we constructed and examined a number of luciferase expression vectors containing various downstream regions in addition to the 2-kb upstream region (Fig. 1A) . The luciferase construct pGL2+BB10, which carries 2 kb ofthe 5' flanking region plus a 10-kb fragment including the first intron through 2-kb downstream of the polyadenylylation site (Fig. 1A) , conferred high levels of expression in the glial cell lines RT4-D and C6 and the stem cell line RT4-AC, but not in neuronal cell lines RT4-E and PC12 or in cell lines from other rat tissues (Fig. 1A) . These data confirm the results obtained by permanent transfection described above, and further show that the regions which pGL2+BB10 contains are sufficient to suppress GFAP expression not only in neuronal cell types but also in nonneural cell types.
To better define the regulatory region(s), deletion mutants of pGL2+BB10 were made and tested as shown in Fig. 1A and Fig. 3 . The results with these constructs revealed that two regions were required for the suppression of the expression of GFAP in neuronal cell lines. One, termed GDR1, is located in a 2.7-kb region extending from the first intron through the fifth exon. The other, termed GDR2, is located in a 1.7-kb region downstream of the polyadenylylation site (Fig. 1A) . GDR1 and GDR2 were functional when placed upstream of the 2-kb 5' flanking region (Fig. 1B) . Therefore, GDR1 and GDR2 function in a position-independent manner, similar to other "silencers" (31) . The presence of both regions was necessary for suppression of GFAP gene expression in neuronal cell types (construct pGL2+BS+SB, Figs. 1 and 3) . However, for suppression ofGFAP expression in nonneural cells, only GDR1 was necessary (construct pGL2+BS, Figs. 1 and 3) . The construct pGL2+X3.2, which carries only GDR2 (Fig. 1A) Luciferase activity of various cell lines with the pGL2+BS+SB expression vector, which carries both GDR1 and GDR2 (see Fig. 1 for detail) . Values of the luciferase activity of pGL2+BS or pGL2+BS+SB were normalized to the activity of pSluc2 (control) transfectants for each of the cell lines shown in Fig. 1 . cell lines, and therefore GDR2 alone is not sufficient for either tissue-specific or cell type-specific suppression.
DISCUSSION
We conclude from these results that GDR1 is responsible for tissue (neural)-specific expression and that GDR1 and GDR2 together are responsible for the cell type (glial)-specific expression of GFAP (Fig. 4) Other groups have described the presence of glial-specific positive elements located upstream of the transcription start site in the mouse or human GFAP genes. Miura et al. (30) reported that only a 256-bp region 5' of the transcription start site is necessary for cell type (glial)-specific expression of the mouse GFAP gene. Sarid (33) , also using the mouse GFAP gene, reported that only the 5' flanking region is necessary for C6 rat glioma-specific expression. Besnard et al. (34) , using the human GFAP gene in human astrocytes and other tissuederived cell lines, reported that the 2-kb 5' flanking region alone allowed expression in glial cells. According to our results, expression vectors containing at least up to 10.8 kb upstream of the transcription start site were expressed not only in glial cells but also in neuronal and nonneural cells. As will be described elsewhere (R.K., N. Hagiwara, K. Leader, and N.S., unpublished work), we have discovered cAMPresponsive enhancer elements upstream of the transcription start site. These enhancer elements may be equivalent to some of the positive regulators described by others.
On the basis of our results, we propose the following hypothesis to be tested on the mechanism of GFAP gene expression. During development, those cells that differentiate into nonneural tissues have a negative regulatory factor(s) that binds to GDR1 and inhibits expression of GFAP. This ubiquitous repressor (UbR) may be functional in all nonneural tissues. In contrast, those cells that differentiate toward neural precursor cells (neuronal-glial stem cells) lack UbR, or UbR is inactivated by a neural-specific factor (NSF). When neural stem cells convert to neuronal cell types, neuronal cells synthesize the negative factor (neuronal downstream repressor, NDR) which binds to GDR2, and this complex interacts with GDR1 to stop the transcription. Alternatively, the NDR-GDR2 complex may reactivate UbR to bind to GDR1 and inhibit transcriptional initiation. We do not exclude the possibility that the function of GDR1 is involved in chromatin-mediated suppression of the GFAP gene (35) .
Expression vectors such as pGL2+BB10 and pGL2+BS+ SB are complete regulatory vectors. These vectors include most, if not all, regulatory elements for the expression of the GFAP gene in various cell types with respect to both tissueand cell type-specific regulation and also for cAMPresponsive expression in stem cell and glial cell types. These regulatory vectors (pGL2+BB10 and pGL2+BS+SB) of the GFAP gene are expected to be useful for the expression of proteins exclusively in glial cells paralleling GFAP expression. Further analysis of GDR1 and GDR2 and the identification of factors that bind to these elements should provide crucial information about the mechanisms of tissue-specific and cell type-specific regulations of gene expression in development of the nervous system.
